MedAdvisor Limited is expecting a larger than usual seasonal increase in usage of its US-based digital platform, inMotion, as the flu season in the US kicks in and the COVID-19 awareness program expands through to the end of 2022. MedAdvisor has increased digital access to patients by 50% in the US through additional pharmacy support of the inMotion digital communications solution. It recently signed an inMotion agreement with a pharmacy software group representing over 10,000 pharmacies in the US, for an initial two year term (followed by automatic one year renewal terms unless either party opts to not renew). This, in combination with additional national
and regional pharmacy groups now supporting inMotion, has increased MedAdvisor's US network from around 20,000 to over 30,000 pharmacy locations with an ability to reach over 60 million individuals via the inMotion digital communications solution. The Company notes that, whilst this agreement will not of itself increase revenue, it may indirectly do so by providing the increased network for the provision of MedAdvisor's programs.